2 unknown. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Unknown 2 |
Follow Random Allocation: new trials by email Literature Review of Random Allocation trials Research Report on Random Allocation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older randomized, double-blinded, placebo-controlled - Prevention of COVID-19 Caused by SARS-CoV-2 | Early Phase 1 | Unknown | Yu Qin | 3300 | 2022-12-27 | 2023-01-11 |
| Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation NK cells - NK Cell Mediated Immunity | Early Phase 1 | Unknown | Shenzhen Fifth People's Hospital | 10 | 2018-01-01 | 2019-12-06 |
Shenzhen Fifth People's Hospital (1) · Yu Qin (1)
China (2)